GV
₹48.01
-1.99(-3.98%)
GVBL₹48.01-3.98%
Value & Investment Index
VIIVII Detail
90 days · zone the stock traded inMultiples vs Peers
Quality Scores
Versus Its Own History
P/E · P/B percentile bandsScenario analysis
stated assumptions, shown workingsGVBL valuation summary
Genomic Valley Biotech Ltd trades at 1048.0 times trailing earnings. Return on equity is 0.8% and return on capital employed is 1.0%. That P/E equals an earnings yield of 0.1%. The median P/E across 22 listed Biotechnology companies is 48.0, so Genomic Valley Biotech Ltd trades at a 1566% premium to that median.
| P/E | 1048.0 |
|---|---|
| ROE | 0.8% |
| ROCE | 1.0% |